I specialize in advising cutting-edge life sciences companies on reimbursement and compliance issues related to their products.
Erik Schulwolf’s practice involves extensive work with molecular diagnostic laboratories and manufacturers of diagnostic tests on issues including reimbursement from government and private payers, compliance with fraud and abuse and federal price reporting laws, and advocacy with federal and state agencies. Erik also provides reimbursement, compliance, and federal and state government strategies advice to pharmaceutical manufacturers and providers.
As an associate in the Life Sciences Coverage & Payment group, Erik has worked with medical device manufacturers and healthcare providers on a wide array of reimbursement and compliance matters under federal and state law. Erik has considerable experience with developing reimbursement strategies, preparing advocacy approaches with federal agencies (in particular, the Centers for Medicare & Medicaid Services), and drafting federal and state legislation.
"The History of Rebates in the Drug Supply Chain and HHS’ Proposed Rule to Change Safe Harbor Protection for Manufacturer Rebates," Foley Hoag White Paper (March 2019)
Foley Hoag Publications
Honors & Involvement
HONORS
Senior Policy Editor, Harvard Law & Policy Review
Speaking Engagements
“Outlook on Value-Based Contracting – Market Realities and Considerations,” CBI’s Strategic Medicare Contracting Forum (November 2019)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
